Pfizer's Quest to Stay Ahead of the Pack
Pfizer’s Quest to Stay Ahead of the Pack
The drugmaker has been a stable holding in unstable times. Now, though, it faces big challenges from rivals to its Lipitor and Viagra
Pfizer’s Quest to Stay Ahead of the Pack
The drugmaker has been a stable holding in unstable times. Now, though, it faces big challenges from rivals to its Lipitor and Viagra
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!